These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 26032999)

  • 21. Increase of drug use and genotype 3 in HCV-infected patients from Central West and Northeast Mexico.
    Muñoz-Espinosa LE; Trujillo-Trujillo ME; Martínez-Macías RF; Panduro A; Rivas-Estilla AM; Fierro NA; Silvera-Linares AL; Torres-Valadez R; Cordero-Pérez P; González-Aldaco K; Chen-López CY; José-Abrego A; Zuñiga-Noriega JR; Gutiérrez-Ruiz MC; Roman S
    Ann Hepatol; 2015; 14(5):642-51. PubMed ID: 26256892
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Medical resource utilization and costs among Australian patients with genotype 1 chronic hepatitis C: results of a retrospective observational study.
    McElroy HJ; Roberts SK; Thompson AJ; Angus PW; McKenna SJ; Warren E; Musgrave S
    J Med Econ; 2017 Jan; 20(1):72-81. PubMed ID: 27552282
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence and outcome of post-transfusion hepatitis C acquired at different ages and detected in look-back screening.
    Millbourn C; Psaros Einberg A; Lindh G; Hökeberg I; Fischler B; Lindahl K
    Scand J Gastroenterol; 2018; 53(7):870-875. PubMed ID: 29909701
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis C-related cirrhosis will be a marginal cause of hospital admissions by 2025.
    Rodríguez-Tajes S; Pocurull A; Castillo J; Casanova G; Vega L; Lens S; Mariño Z; Londoño MC; Forner A; Torres F; Forns X
    J Hepatol; 2020 Dec; 73(6):1360-1367. PubMed ID: 32697948
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical Features and Outcomes of Patients With Genotype 3 Hepatitis C Virus Infection in Korea: A Retrospective Observational Study.
    Cha RR; Lee SS; Lee CM; Ji SB; Jung HC; Cho HC; Kim JJ; Lee JM; Kim HJ; Ha CY; Kim HJ; Kim TH; Jung WT; Lee OJ
    Medicine (Baltimore); 2016 Feb; 95(6):e2755. PubMed ID: 26871824
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prior to the oral therapy, what do we know about HCV-4 in Egypt: a randomized survey of prevalence and risks using data mining computed analysis.
    Abd Elrazek AE; Bilasy SE; Elbanna AEM; Elsherif AEA
    Medicine (Baltimore); 2014 Dec; 93(28):e204. PubMed ID: 25526438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A multicentre, observational study on demographic and disease characteristics of patients seeking care for chronic hepatitis C in Belgium in 2016.
    Bourgeois S; Mulkay JP; Lasser L; Robaeys G; Bastens B; Delwaide J; Pollet S; Van den Enden M
    Acta Gastroenterol Belg; 2019; 82(1):43-52. PubMed ID: 30888753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic hepatitis C patients prior to broad access to interferon-free treatments in Germany.
    Hüppe D; Buggisch P; Christensen S; Heiken H; Mauss S; Naumann U; Fischer C; Kleine H; Huelsenbeck J
    Z Gastroenterol; 2016 Aug; 54(8):740-7. PubMed ID: 27529525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Consensus on management of hepatitis C virus infection in resource-limited Ukraine and Commonwealth of Independent States regions.
    Colombo MG; Musabaev EI; Ismailov UY; Zaytsev IA; Nersesov AV; Anastasiy IA; Karpov IA; Golubovska OA; Kaliaskarova KS; Ac R; Hadigal S
    World J Gastroenterol; 2019 Aug; 25(29):3897-3919. PubMed ID: 31413526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis C virus risk factors in the Turkish community.
    Yildirim B; Tahan V; Ozaras R; Aytekin H; Mert A; Tabak F; Senturk H
    Dig Dis Sci; 2005 Dec; 50(12):2352-5. PubMed ID: 16416188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cascade of Care for Hepatitis C Virus Infection Within the US Veterans Health Administration.
    Maier MM; Ross DB; Chartier M; Belperio PS; Backus LI
    Am J Public Health; 2016 Feb; 106(2):353-8. PubMed ID: 26562129
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The new era of hepatitis C virus therapy.
    Al-Judaibi B
    Saudi J Gastroenterol; 2015; 21(6):345-54. PubMed ID: 26655128
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment guidelines for Hepatitis C in Spain.
    Crespo-Casal M
    Rev Esp Sanid Penit; 2015; 17(2):37-47. PubMed ID: 26191787
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Historical epidemiology of hepatitis C virus (HCV) in select countries - volume 3.
    Liakina V; Hamid S; Tanaka J; Olafsson S; Sharara AI; Alavian SM; Gheorghe L; El Hassan ES; Abaalkhail F; Abbas Z; Abdou A; Abourached A; Al Braiki F; Al Hosani F; Al Jaberi K; Al Khatry M; Al Mulla MA; Al Quraishi H; Al Rifai A; Al Serkal Y; Alam A; Alashgar HI; Alawadhi S; Al-Dabal L; Aldins P; Alfaleh FZ; Alghamdi AS; Al-Hakeem R; Aljumah AA; Almessabi A; Alqutub AN; Alswat KA; Altraif I; Alzaabi M; Andrea N; Assiri AM; Babatin MA; Baqir A; Barakat MT; Bergmann OM; Bizri AR; Blach S; Chaudhry A; Choi MS; Diab T; Djauzi S; El Khoury S; Estes C; Fakhry S; Farooqi JI; Fridjonsdottir H; Gani RA; Ghafoor Khan A; Goldis A; Gottfredsson M; Gregorcic S; Hajarizadeh B; Han KH; Hasan I; Hashim A; Horvath G; Hunyady B; Husni R; Jafri W; Jeruma A; Jonasson JG; Karlsdottir B; Kim DY; Kim YS; Koutoubi Z; Lesmana LA; Lim YS; Löve A; Maimets M; Makara M; Malekzadeh R; Matičič M; Memon MS; Merat S; Mokhbat JE; Mourad FH; Muljono DH; Nawaz A; Nugrahini N; Priohutomo S; Qureshi H; Rassam P; Razavi H; Razavi-Shearer D; Razavi-Shearer K; Rozentale B; Sadik M; Saeed K; Salamat A; Salupere R; Sanai FM; Sanityoso Sulaiman A; Sayegh RA; Schmelzer JD; Sibley A; Siddiq M; Siddiqui AM; Sigmundsdottir G; Sigurdardottir B; Speiciene D; Sulaiman A; Sultan MA; Taha M; Tarifi H; Tayyab G; Tolmane I; Ud Din M; Umar M; Valantinas J; Videčnik-Zorman J; Yaghi C; Yunihastuti E; Yusuf MA; Zuberi BF; Gunter J
    J Viral Hepat; 2015 Dec; 22 Suppl 4():4-20. PubMed ID: 26513445
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A mathematical model by route of transmission and fibrosis progression to estimate undiagnosed individuals with HCV in different Italian regions.
    Kondili LA; Andreoni M; Alberti A; Lobello S; Babudieri S; De Michina A; Merolla R; Marrocco W; Craxì A
    BMC Infect Dis; 2022 Jan; 22(1):58. PubMed ID: 35038987
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis C virus infection impacts work productivity and fatigue: An epidemiologic real-life study.
    de Ledinghen V; Hanslik B; Moussalli J; Si Ahmed SN; Ouzan D; Larrey D
    Ann Hepatol; 2019; 18(5):708-714. PubMed ID: 31164266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of chronic hepatitis C virus infection among childhood cancer survivors in Stockholm, Sweden.
    Psaros Einberg A; Ekman AT; Söderhäll S; Millbourn C; Lindahl K; Harila-Saari A; Fischler B
    Acta Oncol; 2019 Jul; 58(7):997-1002. PubMed ID: 30761933
    [No Abstract]   [Full Text] [Related]  

  • 38. Characterization of chronic HCV infection in Northwest Spain: Impact of the treatment strategic plan of the Spanish National Health Service on HCV cure.
    Grandal M; Pernas B; Mariño A; Álvarez H; Tabernilla A; Castro-Iglesias Á; Mena Á; Delgado M; Pértega S; Poveda E
    J Med Virol; 2017 Jul; 89(7):1304-1308. PubMed ID: 28079256
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic hepatitis C virus infection in the Czech Republic and Slovakia: an analysis of patient and virus characteristics.
    Skladaný L; Oltman M; Fraňková S; Dražilová S; Husa P; Šperl J; Hejda V; Urbánek P; Adamcová-Selčanová S; Janičko M; Kristian P; Kupčová V; Rác M; Schréter I; Virág L; Liptáková A; Ondrášová M; Jarčuška P
    Int J Public Health; 2020 Dec; 65(9):1723-1735. PubMed ID: 33040165
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of thrombocytopenia among patients with chronic hepatitis C: a systematic review.
    Louie KS; Micallef JM; Pimenta JM; Forssen UM
    J Viral Hepat; 2011 Jan; 18(1):1-7. PubMed ID: 20796208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.